08:55 AM EDT, 05/15/2025 (MT Newswires) -- Cybin ( CYBN ) said Thursday that contract drug manufacturer Thermo Fisher Scientific ( TMO ) will provide capsule clinical supply for CYB003, Cybin's ( CYBN ) deuterated psilocin program in late-stage development for the adjunctive treatment of major depressive disorder or MDD.

The clinical-stage company said Thermo Fisher will also support potential commercial manufacturing for CYB003.

Cybin ( CYBN ) said production of both the drug substance and the drug product will be performed at Thermo Fisher's US pharma services manufacturing sites.